
Tympanogen
Developer of medical devices for ear, nose, and throat (ENT) designed to replace traditional surgical procedures with clinic visits. The company's devices include wound-healing therapies that replace ...
Valuation
$20.6M
Latest known
Share Price
N/A
Total Raised
$6M
Last Round
N/A